We are live on
!
Find out more
Amphastar Pharmaceuticals
AMPH
AMPH
222 hedge funds and large institutions have $1.06B invested in Amphastar Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 90 increasing their positions, 74 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
164% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 14
22% more repeat investments, than reductions
Existing positions increased: 90 | Existing positions reduced: 74
9% more funds holding
Funds holding: 203 → 222 (+19)
0.6% more ownership
Funds ownership: 61.98% → 62.58% (+0.6%)
1% less capital invested
Capital invested by funds: $1.07B → $1.06B (-$7.7M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
90% less call options, than puts
Call options by funds: $6.06M | Put options by funds: $60.7M
Holders
222
Holders Change
+19
Holders Change %
+9.36%
% of All Funds
3.74%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
37
Increased
90
Reduced
74
Closed
14
Calls
$6.06M
Puts
$60.7M
Net Calls
-$54.6M
Net Calls Change
-$19.7M
Top Buyers
| 1 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
+$9.81M |
| 2 |
Morgan Stanley
New York
|
+$9.43M |
| 3 |
State Street
Boston,
Massachusetts
|
+$7.81M |
| 4 |
Goldman Sachs
New York
|
+$7.61M |
| 5 |
CM
Castleark Management
Chicago,
Illinois
|
+$6.87M |
Top Sellers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$12.7M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$7.99M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$7.3M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$7.01M |
| 5 |
PCM
Penserra Capital Management
Orinda,
California
|
-$6.42M |
